Abstract:The substantial growth of R&D expenditures over the last two decades, together with the continuous substitution of knowledge (intangible) capital for physical (tangible) capital in corporate production functions, has elevated the importance of R&D in the performance of business enterprises. At the same time, however, the evaluation of corporate R&D activities by investors is seriously hampered by antiquated accounting rules and insufficient disclosure by corporations. Despite the fact that the expected benefits of R&D stretch over extended periods of time, corporate investments in R&D are immediately written off in financial reports, leaving no trace of R&D capital on balance sheets and causing material distortions of reported profitability. After a brief review of statistics documenting the growth and economic importance of corporate R&D in the U.S., the article presents a comparison of R&D disclosure regulations among industrialized nations that shows U.S. rules to be the least flexible in allowing management discretion in how they measure and report R&D. Next the author surveys the large and growing body of empirical research on R&D, which provides strong testimony to the substantial contribution of R&D to corporate productivity and shareholder value. Moreover, despite widespread allegations of stock market “short termism” throughout the 1980s and early '90s, the research indicates “unequivocally” that capital markets consider investments in R&D as a significant value‐increasing activity. But if investors clearly demonstrate a willingness to take the long view of R&D, there is also evidence of undervaluation of some R&D‐intensive companies—particularly those with low profitability—as well as other potential costs to corporations and investors stemming from inadequate public information about R&D. To help correct the reporting biases and distortions of R&D, the author offers some suggestions for investors and analysts that follow R&D‐intensive companies. In particular, he proposes (1) adjustment of reported data to reflect the capitalization and amortization of (instead of expensing) corporate R&D and (2) the use of various quantitative measures for gauging research capabilities and output, including citations of the firm's patents and measures indicating the share of current revenues coming from products developed within recent years.

Searching for an effective measure of R&D performance

Performance measurement in R&D: exploring the interplay between measurement objectives, dimensions of performance and contextual factors

A model for R&D performance measurement

Evaluating R&D Effectiveness: a Study on Chinese Practice and Trend

Measuring R&D Effectiveness—I

Performance measurement in industrial R&D

The Measurement of Open Innovation Performance: Theoretical Model and Its Empirical Verification

Managing innovation performance: Results from an industry‐spanning explorative study on R&D key measures

R&D inputs, firm size and innovation performance: Evidence from Chinese high-tech industry

INNOVATION STRATEGY AND THE USE OF PERFORMANCE MEASURES

Performance Measurement System and Relationships with Performance Results

Innovation and Performance: The Impact of Investments in R&D According to the Different Levels of Productivity of Firms

The Relationship Between R&D and Company Performance

R&D activity and firm performance: mapping the field

R&D AND CAPITAL MARKETS

Utilizing the balanced scorecard for R&D performance measurement

R\&D evaluation methodology based on group-AHP with uncertainty

A Review on Theoretical Research on Performance Measurement of Technological Innovation of Domestic and Foreign Enterprises

Evaluating firms' R&D performance using best worst method

An effective R&D performance measurement system: survey of Korean R&D researchers

Innovation and performance in engineering design